CELAGENEX RESEARCH (INDIA) PVT LTD

REJIYANA Capsule 10's

MRP ₹215.60 (Inclusive of all taxes)
Deliver to

    Netmeds First Membership

    Starting at just ₹[] for 3 months.
    View Plans

    Introduction About REJIYANA CAPSULE

    Rejiyana capsules combine Acetyl-L-carnitine (500 mg) and Agmatine (250 mg), specially formulated to aid in managing moderate to severe depression. This unique dual-action nutraceutical works by:

    • Enhancing brain health: It upregulates Claudin-5 and strengthens the blood-brain barrier.
    • Neuroprotection and mood support: Agmatine, a decarboxylated form of L-arginine, provides neuroprotective, antioxidant, anxiolytic, and antidepressant benefits.
    • Cognitive improvement: Acetyl-L-carnitine helps improve brain energy by supporting the powerhouses of cells (mitochondria). It boosts communication between brain cells, supports mood by balancing serotonin (a feel-good chemical), and may improve brain health by increasing BDNF, a protein that helps protect and repair brain cells, especially when used alongside regular antidepressants.

    Take 1 capsule twice daily (BID) after meals or as advised by your healthcare provider. Always consult your doctor before starting or adjusting any medication. Do not exceed the recommended daily dosage. Before taking Rejiyana Capsule inform your doctor if you have any health condition or pregnant or breastfeeeding as a precaution.

    Key Composition

    • Acetyl-L-carnitine 500 mg + Agmatine 250 mg

    References

    1. Agmatine and Acetyl L Carnitine - A Novel Adjunctive Therapy for Management of Alcohol Withdrawal Syndrome. International Journal of Science and Research (IJSR). January 2023. [Accessed on 18th Jan 2025]. Click here
    2. Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis. NIH. National Library of Medicine. 2018. [Accessed on 18th Jan 2025]. Click here
    3. Agmatine. DrugBank. Click here
    4. N-Acetylcysteine for the Treatment of Psychiatric Disorders: A Review of Current Evidence. NIH. National Library of Medicine. 2018. [Accessed on 18th Jan 2025]. Click here

    Author Details

    Written By Srilekha. R - B.Pharm
    Reviewed For Accuracy By Dr. Narayanasetty Sai Swaroop - Pharm.D
    Last updated on 18 Jan 2025 | 11:25 AM(IST)
    Lab updated